摘要
目的:大肠癌(CRC)在年轻人群的发病率程上升趋势;但这些年轻患者的特征和预后还不完全明确。本回顾性研究目的是分析中国30岁以下结直肠癌患者的临床病理特征。 方法:我们从上海长征医院1995年1月至2013年12月期间患原发性大肠癌的5830名病人中,选取了年龄在13-30岁的83名直肠癌患者(平均年龄26.1岁,其中33名为男性、50名女性)的临床病理特征进行回顾分析。 结果:从出现症状到确诊时间为3天到24个月(平均4.6个月)。诊断时最常见的症状是便血,占所有患者的66.3%。60.2%的患者在直肠出现肿瘤,72.8%出现肿瘤晚期疾病(TNM 三期或四期)。相对于女性患者,更多男性患者出现在M1期。大肠癌转移患者在诊断是抱怨疲劳,这点与未转移患者比较具有显著性差异(31.0% 对5.8%, p = 0.002), 但两组排便习惯改变差异性较小(38%对65.4%,P = 0.017)。此外,转移患者组合未转移患者组的肿瘤组织学分布有统计学意义差异(P = 0.021)。 结论:与老年大肠癌患者相比,年轻的大肠癌患者(<30岁)有更高频次的粘液腺癌,更恶性疾病和差的预后。年轻大肠癌患者临床病理特征的识别将有助于该类特殊患者组的临床诊断和治疗。
关键词: 中国人群,临床病理特征,大肠癌,年轻人
图形摘要
Current Cancer Drug Targets
Title:Clinicopathological Characteristics of Chinese Colorectal Cancer Patients under 30 Years of Age: Implication in Diagnosis and Therapy
Volume: 15 Issue: 1
Author(s): Changpeng Zhu, Meng Ji, Weiping Dai, Changhong Ye, Zhiqian Hu, Jian Shi, Xin Zeng and Yong Lin
Affiliation:
关键词: 中国人群,临床病理特征,大肠癌,年轻人
摘要: Objectives: The incidence of colorectal cancer (CRC) is increasing in younger populations; the characteristics and prognosis of those younger patients are not fully understood. The aim of this retrospective study was to analyze the clinicopathological features of Chinese CRC patients under 30 years of age.
Methods: We reviewed the clinical and pathological features of 83 CRC patients (33 males and 50 females) aged 13-30 years (mean, 26.1 years) selected from consecutive 5,830 patients with primary CRC referred to Shanghai Changzheng Hospital between January 1995 and December 2013.
Results: The duration from the onset of symptoms to diagnosis ranged from 3 days to 24.0 months (average 4.6 months). The most common symptom at the time of diagnosis was bloody stool, occurring in 66.3% of the patients. 60.2% patients had tumors located in the rectum and 72.8% of them presented advanced diseases (TNM stage III or IV). More male patients presented as M1 stage than the female patients. Patients with CRC metastasis complained of more fatigue at the time of diagnosis than their counterparts without metastasis (31.0% vs. 5.8%, p = 0.002), but had less pronounced bowel habit change (38.0% vs. 65.4%, p = 0.017). Additionally, there were differences in histologic distributions of the tumors between patients with and without metastasis (p = 0.021).
Conclusions: Compared with older CRC patients, younger CRC patients (<30 yr) have a higher frequency of mucinous adenocarcinomas, more aggressive diseases and poorer prognosis. Identification of clinicopathological characteristics in younger CRC patients would help diagnose and treat the disease in this unique group of CRC patients in the clinic.
Export Options
About this article
Cite this article as:
Changpeng Zhu, Meng Ji, Weiping Dai, Changhong Ye, Zhiqian Hu, Jian Shi, Xin Zeng and Yong Lin , Clinicopathological Characteristics of Chinese Colorectal Cancer Patients under 30 Years of Age: Implication in Diagnosis and Therapy, Current Cancer Drug Targets 2015; 15 (1) . https://dx.doi.org/10.2174/1568009615666150101115800
DOI https://dx.doi.org/10.2174/1568009615666150101115800 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Immunotherapy of Malignant Gliomas Using Autologous and Allogeneic Tissue Cells
Anti-Cancer Agents in Medicinal Chemistry Targeting p73 - a Potential Approach in Cancer Treatment
Current Pharmaceutical Design Transporters at CNS Barrier Sites: Obstacles or Opportunities for Drug Delivery?
Current Pharmaceutical Design Novel Platelet Signalling Pathways Identified via Proteomics
Current Proteomics Aurora A and B Kinases - Targets of Novel Anticancer Drugs
Recent Patents on Anti-Cancer Drug Discovery Development and Characterization of Biodegradable Polymeric Microspheres of Metformin Hydrochloride
Nanoscience & Nanotechnology-Asia The Association Between the Chronic Use of Non-Steroidal Anti- Inflammatory Drugs and Oxidative and Inflammatory Markers in the Elderly
Inflammation & Allergy - Drug Targets (Discontinued) Functional Genomic Approaches Targeting the Wnt Signaling Network
Current Drug Targets p16<sup>INK4</sup> as a Biomarker in Oropharyngeal Squamous Cell Carcinoma
Recent Patents on Biomarkers Epitope Identification and Discovery Using Phage Display Libraries: Applications in Vaccine Development and Diagnostics
Current Drug Targets Application of Decoy Oligonucleotides as Novel Therapeutic Strategy: A Contemporary Overview
Current Drug Discovery Technologies Beyond Oncolytic Virotherapy: Replication-Competent Retrovirus Vectors for Selective and Stable Transduction of Tumors
Current Gene Therapy Effect of Hsp90 Inhibitor KW-2478 on HepG2 Cells
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Cancer Biomarkers from Bench to Bedside)
Current Cancer Drug Targets Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry Protein Phosphatase 1 and Its Complexes in Carcinogenesis
Current Cancer Drug Targets An Overview of Targeting Legumain for Inhibiting Cancers
Current Pharmaceutical Design Formulation, Characterization and <i>In-vitro</i> and <i>In-vivo</i> Evaluation of Capecitabine Loaded Niosomes
Current Drug Delivery Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety Meet Our Editorial Board Member
Recent Patents on Drug Delivery & Formulation